C12N 5/0629
Keratinocytes
Official title: {Keratinocytes; Whole skin}
C12N5/0629 (Keratinocytes) appears on 274 US grants and 435 published applications in this corpus.
Search patents in C12N- Granted patents
- 274
- Published applications
- 435
- Assignees
- 285
- Inventors
- 891
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 10 | 0 |
| 1998 | 10 | 0 |
| 1999 | 8 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 5 |
| 2002 | 12 | 16 |
| 2003 | 6 | 18 |
| 2004 | 3 | 11 |
| 2005 | 5 | 12 |
| 2006 | 5 | 20 |
| 2007 | 4 | 19 |
| 2008 | 4 | 11 |
| 2009 | 6 | 15 |
| 2010 | 5 | 13 |
| 2011 | 10 | 13 |
| 2012 | 8 | 16 |
| 2013 | 5 | 17 |
| 2014 | 12 | 10 |
| 2015 | 12 | 10 |
| 2016 | 5 | 14 |
| 2017 | 6 | 14 |
| 2018 | 13 | 25 |
| 2019 | 10 | 29 |
| 2020 | 10 | 24 |
| 2021 | 9 | 20 |
| 2022 | 7 | 17 |
| 2023 | 16 | 26 |
| 2024 | 10 | 24 |
| 2025 | 12 | 27 |
| 2026 | 14 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- Engineered gene-editing proteins15 Sep 2026US 12,735,687 B2Factor Bioscience Inc.
- Method for preparing skin-derived pluripotent precursor cells1 Sep 2026US 12,723,232 B2Kao Corporation
- High-porosity nanofiber nonwovens as a support structure for stromal tissue28 Jul 2026US 12,691,203 B2Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V.
- Atraumatically formed tissue compositions, devices and methods of preparation and treatment17 Sep 2026US 2026/0272503 A1TissueMill Technologies LLC
- Cells being highly enriched in sasp factors, and composition comprising said cells17 Sep 2026US 2026/0275282 A1Evomedis GmbH
- Method for producing three-dimensionally cultered skin model comprising hair follicle structure using fibroblasts and three-dimensionally cultered skin model produced thereby20 Aug 2026US 2026/0242727 A1Tego Science Inc.
- Bioassay method for hangeshashinto using pharmacological activity as indicator30 Jul 2026US 2026/0219260 A1Tsumura & Co.
- Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes4 Jun 2026US 2026/0152720 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- System for diagnosis and treatment of wounds390US 5,152,757 AThe Brigham and Women S Hospital, Inc. · 1992
- Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts337US 5,326,356 AFidia S.p.A. · 1994
- Methods of making conditioned cell culture medium compositions249US 6,372,494 B1Advanced Tissue Sciences, Inc. · 2002
- System and method for transplantation of cells92US 5,423,778 A1995
- Gene delivery by microneedle injection92US 6,090,790 A2000